Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
anagliptin (1 trial)
sitagliptin (januvia) (1 trial)
Coronary Artery Disease (Phase 4)
Coronary Disease (Phase 4)
Diabetes Mellitus (Phase 4)
Trials (1 total)
Trial APIs (2 total)